.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Novartis
UBS
Cerilliant
Medtronic
Moodys
Harvard Business School
McKesson
Julphar

Generated: December 13, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLULISINE RECOMBINANT

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis UsAPIDRAinsulin glulisine recombinantINJECTABLE;IV (INFUSION), SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2500-3310 mL in 1 VIAL, GLASS (0088-2500-33)
Sanofi Aventis UsAPIDRAinsulin glulisine recombinantINJECTABLE;IV (INFUSION), SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2502-055 SYRINGE, PLASTIC in 1 PACKAGE (0088-2502-05) > 3 mL in 1 SYRINGE, PLASTIC
Sanofi Aventis UsAPIDRA SOLOSTARinsulin glulisine recombinantINJECTABLE;SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2500-3310 mL in 1 VIAL, GLASS (0088-2500-33)
Sanofi Aventis UsAPIDRA SOLOSTARinsulin glulisine recombinantINJECTABLE;SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2502-055 SYRINGE, PLASTIC in 1 PACKAGE (0088-2502-05) > 3 mL in 1 SYRINGE, PLASTIC
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Novartis
Johnson and Johnson
Julphar
Daiichi Sankyo
Citi
Express Scripts
Moodys
Chubb
Boehringer Ingelheim

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot